Organic impurities can arise during the synthesis, storage, and formulation of drug substances. Identifying and quantifying these impurities is critical for ensuring the safety, efficacy, and quality of pharmaceutical products. BOC Sciences provides comprehensive impurity isolation and identification services to help drug development scientists and project managers characterize unknown degradation products, by-products, and intermediates. Utilizing advanced analytical platforms, we deliver highly accurate data to support robust process optimization and formulation development.
We provide comprehensive profiling of process-related organic impurities generated during synthesis, purification, and scale-up, helping clients better understand impurity sources and improve overall process consistency through advanced impurities identification and characterization.
Our team supports the isolation and structural clarification of unknown organic impurities using integrated chromatographic and spectroscopic strategies, enabling confident impurity assignment for challenging samples and development programs.
We analyze degradation-related organic impurities formed under thermal, oxidative, hydrolytic, or photolytic conditions, supporting product stability understanding and helping clients identify impurity risks throughout storage and formulation development.
Customized analytical methods are developed and optimized to improve the separation, detection, and quantification of organic impurities in APIs, intermediates, and finished formulations, ensuring reliable analytical performance across different sample types.
BOC Sciences delivers precise structural insights and robust quantification for your most complex pharmaceutical samples.
Liquid chromatography coupled with mass spectrometry is highly effective for separating complex mixtures and providing precise molecular weight data for trace organic impurities, facilitating rapid screening and preliminary identification.
Nuclear Magnetic Resonance spectroscopy is indispensable for the definitive structural elucidation of complex degradation products and synthetic by-products, offering unparalleled insight into molecular connectivity and stereochemistry.
When trace impurities need to be isolated for further study, preparative high-performance liquid chromatography enables the extraction of high-purity fractions from bulk matrices, providing sufficient material for advanced spectroscopic analysis.
Gas chromatography-mass spectrometry is utilized for the separation and identification of volatile and semi-volatile organic impurities in drug substances and excipients, ensuring thorough profiling of diverse compound classes.
For highly complex matrices where co-elution occurs, two-dimensional chromatography provides enhanced peak capacity and superior resolving power to effectively separate overlapping impurities that conventional methods might miss.
High-resolution mass spectrometry delivers exact mass measurements, enabling the determination of precise elemental compositions. This capability is crucial for identifying unknown chemical structures and guiding subsequent analytical steps.
BOC Sciences provides comprehensive organic impurity testing across key applications, ensuring product safety, process reliability, and deep molecular understanding.
Share your sample details, and BOC Sciences will design a customized analytical strategy to isolate, identify, and quantify your organic impurities.
Clients provide sample history, synthetic routes, and specific analytical challenges. Our specialists review this information to design a highly targeted investigation plan tailored to the molecule.
Utilizing advanced chromatographic techniques and tailored extraction protocols, we carefully separate the target impurities from the bulk active ingredient and complex excipient backgrounds.
Isolated peaks are subjected to multi-dimensional spectroscopic analysis, including high-resolution mass spectrometry and NMR, to achieve definitive and unambiguous structural determination.
A comprehensive technical report detailing the analytical methodology, structural findings, spectral interpretations, and quantitative data is generated and securely delivered to the client.
We assist chemists in tracking intermediate consumption and by-product formation, enabling the optimization of reaction conditions and purification steps during scale-up to ensure maximum yield and purity. Our analytical support also helps clarify impurity trends across batches, identify process-sensitive steps, and provide the data needed to strengthen overall API process understanding.
We identify forced degradation products and monitor impurity growth over time, providing crucial analytical data to understand molecular liabilities and establish appropriate formulation storage conditions. This approach helps clients better evaluate product stability, recognize degradation-prone pathways, and make more informed decisions on packaging, handling, and long-term storage strategies.
Our team specializes in developing robust analytical methods for complex matrices, ensuring that chromatographic procedures are sensitive, selective, and specific enough to reliably detect trace organic impurities. We also support method refinement for challenging separations, helping clients improve peak resolution, reduce matrix interference, and generate more reliable impurity data for routine analysis.
We provide highly sensitive detection strategies to screen for and monitor potentially mutagenic organic impurities, helping to ensure the overall safety profile of the therapeutic candidate. Our services support early risk identification, trace-level impurity control, and more confident decision-making during process development, candidate selection, and impurity risk evaluation.
Partner with BOC Sciences to resolve complex structural challenges and ensure the purity of your therapeutic compounds. Our experienced scientists provide rapid, dependable analytical insights, enabling confident decision-making in your development workflow.
We leverage an extensive array of high-end analytical equipment, including advanced NMR and HRMS platforms, to tackle the most challenging structural elucidations and trace-level quantifications.
Our seasoned scientists possess extensive backgrounds in organic synthesis and analytical chemistry, allowing for rapid, accurate interpretation of complex spectral data and unique degradation pathways.
From initial detection and chromatographic isolation to definitive structural characterization and custom synthesis of reference standards, we provide a seamless and comprehensive analytical journey.
We understand the time-sensitive nature of pharmaceutical drug development and offer flexible, rapid-response testing strategies designed to keep your critical project milestones firmly on schedule.
Client Needs: A pharmaceutical company observed a new unknown peak, suspected to be an oxidative degradation impurity (specifically a hydroperoxide-induced N-oxide), growing during accelerated stability testing of a solid oral dosage form. They required rapid structural identification to adjust the formulation before pivotal trials.
Challenges: The degradant was present at very low levels (<0.1%) and co-eluted with a major polymeric excipient, making direct mass spectrometry analysis impossible due to severe ion suppression and matrix interference.
Solution: BOC Sciences developed a comprehensive two-dimensional liquid chromatography (2D-LC) approach using heart-cutting technology to efficiently separate the trace impurity from the complex excipient background. This enriched sample was first subjected to HRMS to establish the exact molecular formula. Finally, automated fraction collection combined with advanced micro-cryoprobe NMR analysis provided unambiguous molecular connectivity data.
Outcome: The structure was successfully elucidated as an API-excipient adduct. Armed with this structural insight, the client quickly reformulated using an alternative, non-reactive excipient, saving months of potential development delays.
Client Needs: During the scale-up manufacturing of a novel API, a persistent organic impurity—identified as a process-related impurity, specifically an undesired regioisomer formed during a key cyclization step—appeared, significantly reducing the overall yield and purity profile of the final isolated product.
Challenges: The impurity lacked a strong chromophore, rendering standard UV detection ineffective for isolation. Furthermore, initial screening indicated it shared a nearly identical molecular weight with the desired API, complicating MS interpretation.
Solution: We employed high-resolution mass spectrometry coupled with Charged Aerosol Detection (CAD), which provided a uniform response independent of chromophores, to accurately track and quantify the impurity. To achieve structural elucidation, we scaled up the separation using preparative HPLC to isolate sufficient quantities. This allowed for an extensive suite of 2D NMR experiments (including COSY, HSQC, and HMBC), leading to a definitive and precise structural assignment.
Outcome: The analytical data revealed a rare skeletal rearrangement product. With this knowledge, the client optimized the reaction temperature and solvent system, successfully eliminating the impurity from the scalable synthetic route.
Client Needs: A biotech firm successfully identified a critical organic impurity—a chiral impurity, specifically a stereoisomer featuring a highly constrained macrocyclic ring system—but required a synthesized reference standard to properly quantify its presence in their ongoing preclinical batches.
Challenges: The targeted impurity was highly unstable and required a complex, multi-step asymmetric synthesis that the client's internal chemistry team did not have the capacity or specific expertise to execute rapidly.
Solution: Leveraging our extensive custom synthesis capabilities, our chemistry team designed a novel, convergent synthetic route from scratch. We utilized highly specialized protecting group strategies and strict low-temperature conditions to stabilize the fragile intermediate phases and maintain correct stereochemistry. Following synthesis, the standard was rigorously purified using preparative chiral Supercritical Fluid Chromatography (SFC) and fully characterized via a comprehensive analytical panel.
Outcome: We successfully delivered multi-gram quantities of the high-purity reference standard with a comprehensive Certificate of Analysis (CoA) verified by quantitative NMR (qNMR). This enabled the client to fully validate their analytical methods and maintain their aggressive development timelines.
Organic impurities analysis plays a foundational role in drug development because it directly impacts structural clarity, reaction pathway understanding, and process optimization. By systematically identifying and characterizing potential impurities, development teams can better understand by-product formation and refine synthetic routes. High-quality impurity data also supports early risk assessment and quality strategy design. Service providers like BOC Sciences leverage advanced analytical platforms and experienced teams to help clients achieve rapid identification and mechanistic insights for complex impurities.
In drug development, organic impurities typically originate from starting materials, intermediates, side reactions, and degradation processes. Different sources require tailored analytical strategies, often combining techniques such as HPLC, mass spectrometry, and NMR for multidimensional characterization. Effective strategies involve not only detection but also source tracing and mechanism elucidation to guide process improvements. By integrating multiple technologies, professional service providers can offer comprehensive solutions that help clients fully understand impurity profiles and enhance development efficiency.
Trace-level impurities in complex molecules are often structurally diverse and difficult to isolate, making efficient identification reliant on high-sensitivity instruments and robust data analysis workflows. Techniques such as LC-MS/MS, HRMS, and 2D NMR are commonly combined for structural elucidation, supported by database matching and predictive models. Optimization of sample preparation and separation methods is also essential. BOC Sciences has extensive experience in handling complex systems and provides efficient solutions for challenging impurity identification, helping to accelerate development timelines and improve data reliability.
Impurity profiling is more than analytical output—it is a critical tool for guiding process optimization. By analyzing impurity types, distribution, and trends, scientists can identify risk points in key reaction steps and adjust conditions or materials to minimize unwanted by-products. Comprehensive impurity profiling also helps establish robust quality strategies and improves process predictability. With support from advanced analytical service platforms, development teams gain deeper insights that inform scale-up and continuous improvement decisions.
When selecting an organic impurities analysis partner, clients typically evaluate technical platform breadth, problem-solving capability, and project experience. A strong provider should integrate multiple analytical techniques and handle everything from routine detection to complex structural elucidation. Team expertise and communication efficiency are also key factors. BOC Sciences offers extensive experience in drug development, delivering customized analytical solutions that support projects from early research through advanced stages, ultimately improving overall R&D efficiency.
BOC Sciences quickly resolved our out-of-specification issue by identifying a tricky co-eluting degradant. Their deep structural chemistry knowledge and advanced NMR capabilities are truly unmatched in the industry.
— Dr. Harrison, Principal Scientist, Pharmaceutical Company
The ability to seamlessly transition from complex impurity isolation directly into the custom synthesis of the reference standard makes BOC Sciences an invaluable, end-to-end partner for our API development programs.
— Dr. Lawson, Director of CMC, Biotech Innovator
Their advanced LC-MS and isolation capabilities provided the precise analytical data we needed to optimize our synthetic route. The actionable insights we received helped us significantly improve our overall yield and purity.
— Dr. Thompson, Head of Chemical Development, Contract Manufacturing Organization
We rely on BOC Sciences for their rapid turnaround and highly detailed technical reports. Their robust impurity profiling and quantification services have kept our challenging formulation projects firmly on track.
— Dr. Edwards, Lead Analytical Chemist, Mid-sized Biopharma Company
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
